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Abstract 
Subjecting exponentially growing HeLa cells to heat shock at 45°C for 30 min leads to retarded migration of erkl and erk2, as 
revealed on immunoblots indicating their activation. Renaturation gels confiied activation of erk2 but not erkl. Treatment of cells with 
okadaic acid (OA) alone marginally upregulated erkl and erk2, whereas simultaneous exposure to heat shock and OA led to a 
considerably augmented response for erk2 which was approximately 3-fold higher than the sum of heat- and OA-induced activation. 
Chronic treatment of cells with 12-0-tetradecanoyl-phorbol 13-acetate marginally diminished the extent of erk2 stimulation, but had no 
influence on the OA-induced potentiation of heat-induced erk2 activity. 
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1. Introduction 
MAP kinases play a pivotal role in signal transduction 
pathways (for review see Ref. [l]>. In higher vertebrates, 
this family of proteins consists of at least six members, 
with molecular masses ranging from 40 kDa to 63 kDa 
[2-41. The 42 kDa- (~42 MA’ kinase or erk2) and 44 kDa- 
(p44 MA’ kinase or erkl) forms have been most extensively 
characterized, and their complete primary structures have 
been recently delineated [2,5]. Apart from the 25 N-termi- 
nal amino acids, the sequences share N 85% identity. 
They have in common putative threonyl and tyrosyl phos- 
phorylation sites in the sequence motif TEY, phosphoryla- 
tion of which by the dual specificity MAP kinase/erk 
kinase (MEK) results in activation of erkl and erk2, 
respectively [6,7]. 
Chang and coworkers have recently demonstrated a 
potentiating effect of okadaic acid (OA) on heat-induced 
HSP70 promoter activity [8], and their results suggest that 
phosphatases of the type 2A are involved in suppression of 
HSP70 transcription in unstressed cells. The authors pro- 
posed several hypotheses to account for the potentiating 
effect of OA, all of which involve increased phosphoryla- 
tion of either HSFl, other truns-acting factors or RNA 
polymerase II. 
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Erks could be involved in heat shock-induced phospho- 
rylation enhancement, since several investigators have 
demonstrated these enzymes to be activated by heat in 
HeLa [12] and Swiss 3T3 cells [13] and OA treatment in a 
variety of cell lines [9-111. 
In the current report, we demonstrate heat-induced acti- 
vation of erk2 and possibly erkl, and further show that the 
induction of erk2 is potentiated by simultaneous treatment 
with OA; this latter effect is essentially independent of the 
action of protein kinase C. 
2. Materials and methods 
2.1. Materials 
Okadaic acid (OA) was supplied by Anawa Trading Sa. 
(Wangen, Switzerland), myelin basic protein (MBP) by 
Sigma (Buchs, Switzerland), [ 3/- 32 P]ATP (3000 Ci/mmol) 
by NEN Du Pont (Ziirich, Switzerland) and prestained 
molecular mass markers by Bio-Rad (Glattbrugg, Switzer- 
land). The ECL Western blotting detection kit was pur- 
chased from Amersham (Arnersham, UK). All tissue cul- 
ture media and solutions, as well as 12-O-tetrade- 
canoylphorbol-13-acetate @PA), were supplied by Gibco- 
BRL (Basel, Switzerland) and tissue culture plastics by 
Tecnomara (Wallisellen, Switzerland). 
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2.2. Cell culture, OA-treatment, heat shock and downregu- 
lation of PKC 
HeLa cell monolayers were cultured as described previ- 
ously [14]. OA-treatment: Subconfluent monolayers were 
incubated for 30 min in plastic dishes with 0.4% dimethyl 
sulfoxide in minimal essential medium (MEM), either in 
the absence or presence of 1 PM OA. Heat shock-treat- 
ment: Cells were incubated for 30 min in an oven pre- 
heated to 45°C. They welre then lysed either immediately 
or after a 2 h period at :37”C. If cells were incubated at 
45°C in the presence of 1 PM OA, the medium was 
substituted by fresh, prewarmed (37°C) medium (without 
OA) prior to the incubation at 37°C. Downregulation of 
PKC: Cells were incubated with 1 pg TPA per ml of 
medium for 24 h at 37°C. Western blots of the lysates 
derived from TPA-treated cells revealed that expression of 
PKC (Y and PKC /3 had been virtually abolished. 
2.3. Cell lysis 
Cells were pelleted in a cooled (4°C) Beckman CS6R 
centrifuge for 5 min at 500 X g,. The pellet was washed 
twice with ice-cold phosphate buffered saline (10 mM 
sodium phosphate (pH 7.4); 144 mM sodium chloride), 
and then resuspended in lysis buffer containing 50 mM 
Tris-HCl (pH 7.01, 250 mM sucrose, 1 mM EDTA, 1 mM 
EGTA, 1 mM sodium ‘orthovanadate, 10 mM sodium 
fluoride, 1% Triton X-100 and 0.2 mM phenylmethane- 
sulfonyl fluoride. The cells were incubated for 20 min on 
ice and then centrifuged at 13 000 X g, for 5 min. The 
supematant obtained after this centrifugation is designated 
‘cell lysate’. Protein content was measured according to 
the method of Bradford [15] using bovine serum albumin 
as a standard. 
2.4. Renaturation ofproteins in SDS-gels (‘renatured gels’) 
SDS-PAGE of cell lysates in MBP-containing gels, and 
subsequent renaturation was performed essentially accord- 
ing to the method of Kameshita and Fujisawa [16]. In some 
cases, 1 mg BSA/ml was substituted for MBP in gels. 
Briefly, lysates were separated on 10% SDS-polyacryl- 
amide gels, which were then washed three times in 50 mM 
Tris-HCl (pH 8.0) (Tris-buffer) containing 20% 2-propanol 
to remove SDS. The gels were subsequently equilibrated in 
Tris-buffer (containing 5 mM 2-mercaptoethanol) and then 
denatured in 6 M guanidinium hydrochloride in Tris-buffer 
(three changes). Thereafter, gels were renatured by incuba- 
tion in Tris-buffer containing 0.04% Tween40 with four 
changes overnight. Finally, gels were incubated for 1 h in 
20 ml 40 mM Hepes-buffer (pH 8.0) supplemented with 25 
PM [ 3/-32P]ATP (50 PCi), 2 mM dithiothreitol, 5 mM 
MgCl, and 0.1 mM EGTA. After washing and drying, 
radioactive bands were detected by autoradiography. 
2.5. Immunoblotting 
Lysates were separated on 10% SDS-PAGE and electro- 
transferred in a semi-dry-blotting device (JKA-Biotech, 
Denmark) onto previously wetted PVDF (poly(vinylidene 
difluoride)) membranes. The transfer buffer consisted of 
192 mM glycine and 25 mM Tris; neither methanol nor 
SDS were included. The blots were decorated either with 
antisera recognizing essentially two members of the MAP 
kinase family in HeLa cells, namely, the 42 kDa- (erk2) 
and 44 kDa- (erkl) forms (UBI, Lake Placid, USA), or 
with purified monoclonal antibodies reacting with PKCa 
and PKC/3 (clone MC5, Amersham, UK). Detection was 
achieved using either a polyclonal anti-rabbit serum or a 
polyclonal anti-mouse serum, both labelled with 
horseradish peroxidase. Blots were then incubated with the 
chemiluminescence reagents supplied in Amersham’s ECL 
detection kit (Amersham, UK), essentially according to the 
manufacturer’s instructions. The anti-erks serum was di- 
luted 1:5000 and the purified MC5 1:2000; the 
peroxidase-labelled anti-rabbit and anti-mouse sera were 
used at dilutions of between 1:4000 and 1:lOOOO. 
3. Results 
3.1. Phosphorylation of erkl and erk2 by heat shock 
treatment of HeLa cells 
We investigated the possible activation of erkl and erk2 
by drawing on the well characterized changes in elec- 
trophoretic mobility occurring as a result of multiple phos- 
phorylations (e.g., [17-201). 
HeLa cells were subjected to thermal insult at 45°C for 
30 min and lysed either immediately or after a further 
incubation period of 2 h at 37°C. In order to prevent 
heat-induced alkalinization of the medium [21], 20 mM 
Hepes (final concentration), pH 7.35, was added prior to 
heat shock. Erkl and erk2 were detected using antisera 
against a synthetic peptide modelled from amino acids 333 
to 367 of the C-terminal end of rat erkl (Upstate Biotech- 
nology, Lake Placid, USA). 
In lysates derived from untreated cells, retardation of 
migration is not detected either for erkl or erk2 (Fig. lA, 
lane 11, indicating that the two kinases are inactive. In 
contrast, cells maintained at 45°C for 30 min prior to lysis 
contain a pool of erkl and erk2 molecules with retarded 
electrophoretic mobility (Fig. lA, lane 2, erkl and e&2), 
demonstrating that they have undergone activation. Trans- 
ferring the cells back to 37°C for 2 h after heat shock has 
little effect on this general pattern, since substantial pools 
of erk molecules remain activated (Fig. lA, lane 3); the 
intensities of the bands representing phosphorylated pro- 
teins are somewhat enhanced compared to those seen in 
lane 2 of Fig. 1A. 
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Fig. 1. Activation of erkl, erk2 and additional MBP kinases by heat 
shock or OA-treatment. Lysates (20 pg) of cells which had undergone 
different treatments (see below) were separated on 10% SDS-polyacryl- 
amide gels and either blotted onto PVDF membranes (A) or renaturated 
(B) as described in Section 2. The blots were decorated with antibodies 
recognizing erkl and erk2. Lanes: 1, control cells; 2, cells subjected to 
heat shock (at 4S’C) for 30 min; 3, heat shock for 30 min with subsequent 
recovery at 37°C for 2 h; 4, 1 PM OA for 30 min; 5, 1 PM OA for 30 
min with subsequent incubation for 2 h in drug-free medium; 6, heat 
shock and OA-treatment for 30 min; 7, heat shock and OA-treatment for 
30 min with subsequent incubation at 37°C for 2 h in drug-free medium. 
To determine whether okadaic acid (OA), a well de- 
scribed inhibitor of phosphatases 1 and 2A, interferes with 
the dephosphorylation of an activatory phosphorylation on 
erkl or erk2, this drug was applied at a concentration 
sufficient to inhibit both types of phosphatases [22]. Treat- 
ment of cells with 1 PM OA for 30 min yields the pattern 
depicted in lane 4 of Fig. lA, from which it may be seen 
that the phosphoproteins of erkl and erk2 are barely 
detectable; in cells which have been incubated for a further 
2 h in OA-free medium, they are slightly more pronounced 
(Fig. lA, lane 5). 
The most remarkable effect is observed in cells which 
have received combined OA and heat shock treatment. 
This protocol elicits almost complete activation of both 
erkl and erk2 (Fig. lA, lane 6), as evidenced by the 
retarded migration of most erkl and erk2 molecules. This 
activation persists for at least 2 h, since returning the cells 
to normal temperature in OA-free medium for this period 
of time has no influence on the pattern (Fig. lA, lane 7). 
3.2. In situ renaturation reveals potentiating effect of OA 
on heat-induced activation of erk2 
We further characterized the stimulation of erk activity 
observed in heat shocked HeLa cells and in those treated 
with OA by means of renaturated gels. Cell lysates were 
separated and renatured in one-dimensional SDS-poly- 
acrylamide gels containing 0.5 mg MBP per ml of gel. 
Phosphorylation of MBP by renatured kinases was re- 
vealed by autoradiography of gels incubated with [ y- 
32P]ATP (Fig. 1, panel B). In lysates of untreated cells, 
only a very faint radioactive band, even after prolonged 
exposure of dried gels to the X-ray film, is detectable in 
the region where erkl and erk2 are presumed to migrate 
(Fig. lB, lane 1). Subjecting cells to an elevated tempera- 
ture results in a clearly visible band at around 40 kDa, the 
position assigned for erk2. No band, however, is detected 
for erkl (Fig. lB, lane 2). Transferring the cells back to 
normal temperature for 2 h does not appear to affect this 
pattern, as reflected by almost identical incorporation of 
radioactivity (Fig. lB, lane 3). 
Treatment of cells with OA generates only a faint band 
at around 40 kDa (Fig. lB, lane 4); returning the cells to 
OA-free medium for 2 h prior to lysis has only a slight 
influence on this pattern (Fig. lB, lane 5). 
Heat shock treatment of cells in medium containing OA 
leads to a considerable rise in the MBP-phosphorylation 
activity of the kinase migrating with an apparent molecular 
mass of around 40 kDa, as evidenced by the intense band 
at this level (Fig. lB, lane 6). Radioactivity incorporated 
into this band was around 3-fold higher (17.3 k 3.4 (mean 
f SE.); n = 3) than that expected from the sum of heat- 
(3.1 f 0.6; n = 3) and OA-treatment (1.9 f 0.2; n = 3) 
alone. Incubation of cells for an additional 2 h in OA-free 
medium at 37°C (Fig. lB, lane 7) does not change this 
band pattern. 
3.3. Chronic treatment of cells with TPA does not affect 
the OA-induced potentiation 
In order to establish whether heat shock- or OA-induced 
activation of PKC is a prerequisite for induction of erks, 
we depleted the cells of PKC by incubation in medium 
containing 1 pg TPA/ml for 24 h. They subsequently 
underwent either heat shock, treatment with OA, or both. 
Chronic treatment of cells with TPA leads to the com- 
plete disappearance of immunologically detectable forms 
of PKC (Y and PKCP, as demonstrated (Fig. 2A, lanes 
2-7). In mock-treated (1% DMSO for 24 h) cells the band 
representing PKC is clearly visible (Fig. 2A, lane 1). The 
faint bands observed in immunoblots above the PKC-band 
represent unspecific binding reactions of the antibodies, 
their detection being due to the high sensitivity of the 
chemiluminescense method. 
Analysis of the PKC-depleted cells was performed by 
separating their lysates on SDS-gels which subsequently 
underwent renaturation and autoradiography. 
In mock-treated cells, a very faint band is visible in the 
region where erk2 is assumed to be localized (Fig. 2B, 
lane 1). Similarly, in lysates from cells incubated for 24 h 
with TPA only a faint band is detected in the same region 
(Fig. 2B, lane 2). It has to be noted, however, that expo- 
sure of the films was considerably longer than in the case 
of the separated lysates from cells not treated with TPA. In 
contrast, exposure of cells to an elevated temperature for 
30 min activates the phosphorylating protein at around 40 
kDa (Fig. 2B, lane 3). Transferring cells back to physio- 
logical temperature for an additional 2 h causes a slight 
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Fig. 2. Activation of MBP kinares by heat shock or OA-treatment in cells 
chronically exposed to TPA. Lysates (15 pg) of cells which were either 
mock-treated (lane 1) or exposed to 1 pg TPA/ml for 24 h (lanes 2-8), 
were separated on 8% (panel A) and 10% SDS-polyacrylamide gels 
(panel B). These were then either blotted onto PVDF membranes (A) or 
renatured (B). Blotted lysates were decorated with anti-PKC antiserum. 
Lanes: 1, mock-treatment (1% DMSO for 24 h); 2, control (no acute 
treatment); 3, heat shock treatment at 45°C for 30 min; 4, heat shock for 
30 min with subsequent recovery at 37°C for 2 h; 5, 1 PM OA for 30 
min; 6, 1 PM OA for 30 min with subsequent incubation for 2 h in 
drug-free medium; 7, heat shock and OA-treatment for 30 min; 8, heat 
shock and OA-treatment for 30 min with subsequent incubation at 37°C 
for 2 h in drug-free medium. 
reduction in activity (Fig. 2B, lane 4). OA-treatment of 
cells does not apparently increase the activity of the kinase 
at around 40 kDa (Fig. 2B, lane 5). Exchanging the 
OA-containing medium for an OA-free one, with further 
incubation for 2 h at 37°C has no effect on the activity 
state of the kinase migrating at around 40 kDa (Fig. 2B, 
lane 6). 
The combination of he:at shock and OA-treatment has a 
profound effect on kinase activity of erk2, as revealed by 
the intense radioactive band detected in this molecular 
mass region (Fig. 2B, lane 7). The sum of the radioactivity 
incorporated into this band by each treatment alone is 
3-fold lower than that measured after combined treatment 
(results not shown). If the cells are permitted to recover 
from heat shock and OA-treatment for 2 h, this radioactive 
band almost retains its intensity (Fig. 2B, lane 8). 
4. Discussion 
HeLa cells exposed to thermal insult express increased 
erk2 activity; OA-treatment also has a slight inductive 
effect on the kinase. Most remarkably, concomitant heat- 
and OA-treatment initiates phosphorylation and subsequent 
activation of erk2 molecules. 
Heat shock induction of erk2 in HeLa cells has been 
previously reported by Dubois and Bensaude [12], but 
these authors did not detect phosphorylation of erkl. Since 
we have observed a mobility shift of erkl in serum-starved 
and PKC-depleted cells [23,24], as well as in exponentially 
growing cells, we believe that either slight differences in 
cell line or pH-effects interfered with signal molecules 
involved in phosphorylation properties upstream of erkl in 
their assay system. While phosphorylation was observed 
for both erkl and erk2 after all applied treatments in 
Western blots, the experiments with renaturation gels re- 
vealed increased activation only for erk2, whereas no 
induction of activity could be detected for erkl. It is 
suggested that this discrepancy may be due to a structural 
difference between erkl and erk2. Indications for this 
hypothesis come from a recent study, where it was shown 
that site-directed mutagenesis of corresponding residues in 
erkl and erk2 reduce activities to varying degrees [25]. 
Three-dimensional conformation variances may therefore 
account for the observed discrepancy between phospho- 
rylation and activation of erkl. 
OA-induced activation of erks has been shown by sev- 
eral groups to occur in a variety of cell lines, including rat 
adipocytes [9], PC12 cells [lo] and 3Yl cells [ll], suggest- 
ing that phosphatases of type 1 and type 2A are involved 
in regulation of erks in these cells. We found only marginal 
induction, indicating that, at least in HeLa cells, other 
phosphatases may act on erkl and erk2. This assumption is 
substantiated by the recent discovery of three related dual 
specificity phosphatases that dephosphorylate and thereby 
inactivate very specifically erks [26-301, but it is not yet 
known whether expression or activity of these phospha- 
tases is subject to modulation by OA. 
Of particular interest is the potentiated activation of 
erk2 observed after combined heat shock and OA-treat- 
ment. This cooperativity of erk activation is sustained in 
PKC-depleted cells, even though the overall level of induc- 
tion decreases slightly. PKC is involved in ras-independent 
erk activation pathways [31,18], and could mediate erk 
activation via induction of raf [32]. However, since down- 
regulation of PKC had little effect on heat- and OA-in- 
duced activation of erk2, the PKC-raf pathway does not 
seem to be the only option for heat sensing in HeLa cells. 
Nonetheless, our results do not exclude involvement of 
TPA-insensitive PKC isoforms, e.g., PKC&’ has been 
demonstrated not to respond to chronic TPA treatment in 
rat renal mesangial cells [33]. 
The cooperative effect of OA and heat shock suggests 
that the former agent is interfering with heat-stable or even 
heat-induced phosphatases acting on erkl and erk2. Chang 
and coworkers [8] have recently reported that OA potenti- 
ates heat-induced HSP70-promoter activity in HeLa and 
IMR-90 cells, the promoter of HSP70 containing a binding 
site for the heat-inducible transcription factor HSFl [34- 
361. Upon heat-induction, HSFl trimerizes, translocates to 
the nucleus, becomes hyperphosphorylated, binds to the 
heat shock response element (HSE) and profoundly in- 
creases HSP70 gene transcription [37,38]. The amino acid 
sequence of HSFl [39] contains two motifs which are 
potentially potent phosphorylation sites for erks [40,41]. 
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Hence, we propose that the observed potentiation of erk2 
activation and probably of erkl, by concomitant OA- and 
heat-treatment accounts for at least part of the observed 
HSFl phosphorylation and subsequent transcription activa- 
tion of HSP70 [8]. This proposal is substantiated by the 
observation that considerable pools of erk molecules 
translocate to the nucleus upon activation [42,43]. 
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